Khadim, Azizul IslamShail, Vivek KumarKumar, KanakNaaz, SabihaChakma, Abhijit2024-12-112023https://aoh.ccrhlibrary.in/handle/123456789/906Background: Osteoarthritis (OA) is a progressive, degenerative disease affecting large weight-bearing joints. The severity of symptoms varies among individuals; whereas pain and stiffness are the most troublesome complaints. Homoeopathic medicines have the potential to manage pain episodes. Objective: The aim of the study was to assess the effect of individualised homoeopathic medicine (IHM) in managing the pain of knee and hip OA. Methods: A prospective, double-blind, randomised (1:1) placebo-controlled trial was conducted on 60 individuals suffering from OA at R.B.T.S. Govt. Homoeopathic Medical College and Hospital, Muzaffarpur. Visual analogue scale for pain (Score-A-1), stiffness (Score-A-2) and loss of function (Score-A-3) was the primary outcomes and the OKHQOL scale (Score-B) was the secondary outcome. The outcomes were measured at baseline and after 3 months. Comparative analysis was done to detect group differences. Intra and intergroup analysis was done by paired and unpaired t-tests, respectively. Results: Statistically significant results were observed in both intra and intergroup outcomes (P < 0.05, at 95% CI). The group differences in Score-A-1 (mean difference: ?5.83, 95% CI: ?6.71to?4.94, P < 0.001), Score-A-2 (mean difference: ?5.43, 95% CI: ?6.38to?4.48, P < 0.001), Score-A-3 (mean difference: ?5.60, 95% CI: ?6.50to-4.69, P < 0.001) and in Score-B (mean difference: ?106.87, 95% CI: ?142.77 to?70.96, P < 0.001) were statistically significant after 3 months. However, the improvement was much better in the IHM group than in the placebo group. The frequently indicated medicines were Rhus toxicodendron, Medorrhinum, Bryonia and Syphilinum. Conclusion: This study shows that IHMs can improve the pain in knee and hip OA, as well as the quality of life.HipIndividualised homoeopathic medicineKneeOsteoarthritis knee and hip quality of lifeIndividualised homoeopathic medicine versus placebo in the pain management of knee and hip osteoarthritis: A double-blind, randomised controlled trial